--2025/Q4-- / 414.065B--
--2025/Q3-- / 448.790B--
Oct 30, 20242025/Q2462.497B / 425.282B--
Aug 1, 20242025/Q1473.124B / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--
US Stock MarketDetailed Quotes
ALPMY Astellas Pharma (ADR)
- 10.380
- +0.090+0.87%
15min DelayClose Nov 29 13:00 ET
18.58BMarket Cap51.64P/E (TTM)
10.830High10.230Low52.46KVolume10.830Open10.290Pre Close542.69KTurnover0.00%Turnover Ratio167.42P/E (Static)1.79BShares13.14052wk High1.84P/B18.58BFloat Cap9.15052wk Low0.24Dividend TTM1.79BShs Float18.789Historical High2.27%Div YieldTTM5.83%Amplitude0.508Historical Low10.344Avg Price1Lot Size
Astellas Pharma (ADR) Key Stats
Astellas Pharma (ADR) H1 FY2025 Earnings Date
Currency：JPYOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 916.18B | 935.62B | +19.44B |
| Beat Est. | +19.43% | +21.96% | +4.57% |
| EPS | -- | 40.91 | -- |
+105.58% |
Analyst Rating
No Data
Astellas Pharma (ADR) Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data